Caricamento...

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection

BACKGROUND: Boceprevir and telaprevir have recently showed dramatically better treatment outcomes than conventional PEGylated interferon plus ribavirin for the treatment of hepatitis C virus genotype 1, but the average cost per patient is unknown. METHODS: In the UK context, we performed a budget im...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Thorlund, Kristian, Druyts, Eric, El Khoury, Antoine C, Mills, Edward J
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2012
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3503472/
https://ncbi.nlm.nih.gov/pubmed/23180971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S37205
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !